CJC-1295 (With DAC)
Price range: £36.99 through £45.99
CJC-1295 (With DAC)
Hormonal — GHRH Analogue CJC-1295 is a synthetic GHRH analogue. The DAC (Drug Affinity Complex) variant binds circulating albumin, extending its half-life to several days for sustained growth-hormone elevation rather than the short pulsatile release of the no-DAC form. Target: GHRH receptor Variant: With DAC (long-acting) Half-Life: ~6–8 days
CJC-1295 (With DAC)
Mechanism of Action
CJC-1295 binds the GHRH receptor (GHRHR) on anterior pituitary somatotrophs, stimulating GH synthesis and secretion.
Extended Half-Life via Albumin Binding
The Drug Affinity Complex (DAC) modification covalently attaches to circulating albumin, extending plasma half-life from ~30 minutes (no-DAC) to 6–8 days, producing sustained rather than pulsatile GH/IGF-1 elevation.
No-DAC vs DAC Variants
Because it removes the natural pulsatile pattern of GH release, the DAC form is generally studied separately from — rather than combined with — GH secretagogues like Ipamorelin, which are typically paired with the no-DAC variant instead.
Research compound only — not licensed for human consumption or therapeutic use. Sold strictly for laboratory research purposes.
Vials (Peptides)
Pre-mixed Pens (Peptides)
Nasal Spray (Peptides)
Cream (Peptides)
Reviews
There are no reviews yet.